Concepedia

Paul E. Harrington

PE

Statistics

Publications

28

Citations

1.7K

H-Index

21

Active since

1997

Affiliations

Amgen (United States)(Current)

University of Hawaii System

Merck & Co., Inc., Rahway, NJ, USA (United States)

Stanford University

University of Hawaiʻi at Mānoa

Paul E. Harrington is an author at Amgen (United States) specializing in medicinal chemistry, chemistry, and organic chemistry.

Publications per year

1997–2014

28

Publications

28

Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)

Joey L. Methot, Prasun K. Chakravarty, Mélissa Chénard et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 187 citations · Full text

, , +10

Synthesis and Absolute Stereochemistry of Roseophilin

Paul E. Harrington, Marcus A. Tius · Journal of the American Chemical Society · 2001 · 144 citations

, , +8

Dinuclear Asymmetric Zn Aldol Additions:  Formal Asymmetric Synthesis of Fostriecin

Barry M. Trost, Mathias Frederiksen, Julien P. N. Papillon et al. · Journal of the American Chemical Society · 2005 · 133 citations

, , +11

Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell Viability

Paul E. Harrington, Kaustav Biswas, David J. Malwitz et al. · ACS Medicinal Chemistry Letters · 2014 · 104 citations · Full text

, , +13

Reaction of Indoles with Electron Deficient Olefins Catalyzed by Yb(OTf)<sub>3</sub>⋅3H<sub>2</sub>O

Paul E. Harrington, Michael A. Kerr · Synlett · 2000 · 103 citations

, , +11

1–5 of 28